Sökresultat

Filtyp

Din sökning på "Longqi Liu 2025 single cell spatial omics keynote speaker conference" gav 14647 sökträffar

No title

Mesenchymal stromal (stem) cells (MSCs) are increasingly demonstrated to ameliorate experimentally-induced lung injuries through disease-specific anti-inflammatory actions, thus suggesting that different in vivo inflammatory environments can influence MSC actions. To determine the effects of different representative inflammatory lung conditions, human bone marrow-derived MSCs (hMSCs) were exposed

Previous COMMONS seminars

2026-01-29. Guilio Tesei, Malmö University.Data-driven models of intrinsically disordered proteins and their phase separation2025-12-01. Alessandra LuchiniInvestigating biological membranes: insights from neutron reflectometry2025-09-15. Frank Schreiber, University of Tübingen, GermanyControlling protein behavior by multivalent charges: Liquid-liquid phase separation, crystallization, and beyond20

https://www.commons-center.lu.se/previous-commons-seminars-0 - 2026-07-19

No title

In this study a dynamic model of a solid oxide fuel cell (SOFC) system has been developed. The work has been conducted in a cooperation between the Department of Energy Sciences, Lund University, and Mode Ion AB using the Modelica language and the Dymola modeling and simulation tool. Modelica is an equation based, object oriented modeling language, which promotes flexibility and reuse of code. The

Emma Sparr

Professor Contact details Email: emma [dot] sparr [at] chem [dot] lu [dot] se Phone: +46 46 222 15 36Organisation Physical Chemistry Service point: 1 WebpageEmma Sparrs profile in Lund University research portalOther affiliations Assistant head of office Physical Chemistry Profile area member LU Profile Area: Proactive Ageing Member of Strategic Research Area MultiPark: Multidisciplinary research

https://www.physchem.lu.se/emma-sparr - 2026-07-20

Lars Harrie

Professor Kontaktinformation E-post: lars [dot] harrie [at] mgeo [dot] lu [dot] se Telefon: +46 46 222 01 55Organisation Miljö- och geovetenskapliga institutionen (MGeo) Rumsnummer: GIS centre 104 Hämtställe: 16 WebbplatsLars Harries profil i Lunds universitets forskningsportalAndra roller Biträdande programledare Lantmäteri (CI) Medlem i Strategiskt forskningsområde eSSENCE: The e-Science Collabo

https://www.gis.lu.se/sv/lars-harrie - 2026-07-20

No title

WNT5A has been identified as an important ligand in the malignant progression of a number of tumours. Although WNT5A signalling is often altered in cancer, the ligand's role as either a tumour suppressor or oncogene varies between tumour types and is a contemporary issue for investigators of β-catenin-independent WNT signalling in oncology. Here, we report that one of the initial effects of active

No title

Between 1977 and 1996, cytogenetic investigations were performed on 182 childhood (< or = 16 yr) acute lymphoblastic leukemias (ALL), constituting 94% (182 of 194) of all ALL patients diagnosed and treated at the Departments of Pediatrics, Lund and Malmo University Hospitals, Sweden, during these two decades. The cytogenetic analyses were successful in 152 cases (84%). The failure rate was higher

Osama Mansour

Docent Kontaktinformation E-post: osama [dot] mansour [at] ics [dot] lu [dot] se Telefon: +46 46 222 33 84Organisation Institutionen för informatik Rumsnummer: EC2-235 Hämtställe: 10 WebbplatsOsama Mansours profil i Lunds universitets forskningsportalAndra roller Profilområdesmedlem LU profilområde: Mänskliga rättigheter Publikationer Visar av publikationer. Sorterade efter år och sen titel. Filtr

https://www.ehl.lu.se/osama-mansour - 2026-07-20

Development research day 2017

Microsoft Word - Development Research Day 2017.docx Development Research Day 2017 SEMINARIUM The Development Research Day is an annual event at Lund University bringing together all fields working on development to share and discuss their research with each other, students and the general public. This year’s theme is ”Long-term trends in global inequality and development”, and the day is organized

https://www.svet.lu.se/en/sites/svet.lu.se.en/files/development_research_day_2017.pdf - 2026-07-21

Guidelines for submission of abstracts  

We invite SWEAH PhD students, postdoctoral fellows, supervisors and partner representatives to submit abstracts. Participants are encouraged to indicate their preferred presentation format in the abstract submission process. The time limits described below and preferred presentation format may be subject to change, based on the number of abstracts admitted.  Oral presentation   These presentations

https://sweah.lu.se/en/sweah-conference-2023/guidelines-submission-abstracts - 2026-07-19

Spatial Audio Workshop

4–9 November (workshop 3 incl. exhibition), 7–11 October (workshop 2), 9–13 September 2024 (workshop 1) Spatial audio is currently experiencing a renaissance period through the rise of various extended reality (XR) applications and adoption by mainstream media such as Apple Music, Netflix and major cinema releases. This has occurred alongside rapid spatial audio development within arts, music and

https://www.iac.lu.se/spatial-audio-workshop - 2026-07-19

No title

Popular Abstract in Swedish HIV är en av de dödligaste farsoterna i världen och 30-40 miljoner människor beräknas ha dött AIDS. Genom att konstant förändra sig ligger viruset hela tiden ett steg före immunförsvaret, och immunförsvaret klarar därför inte av att bekämpa infektionen. HIV skiljer sig också från andra virus genom att det drabbar och långsamt utplånar immunförsvaret. Det gör att HIV kanThe two genetically related human lentiviruses known today, HIV-1 (which is pandemic) and HIV-2 (which mainly is confined to West Africa), are the causative agents of AIDS. Progressive immune dysfunction and AIDS develop in most cases of untreated HIV-1 infection, but only in approximately 25-30% of HIV-2 infected individuals. The V1-V3 region of the HIV-1 env gp120 is important for HIV-1 corecept

Course: Handling, maintenance and understanding of human pluripotent stem cells

14 September 2026 09:00 to 18 September 2026 17:00 | Other Are you new to working with human pluripotent stem cells? Experts from the Cell and Gene Technologies Core Facility at Lund University's Lund Stem Cell Center will teach you how from 14 - 18 September, 2026! The 5-day course on the "Handling, maintenance and understanding of human pluripotent stem cells" contains substantial hand-on practi

https://www.intramed.lu.se/en/calendar/course-handling-maintenance-and-understanding-human-pluripotent-stem-cells-0 - 2026-07-19

Course: Handling, maintenance and understanding of human pluripotent stem cells

14 September 2026 09:00 to 18 September 2026 17:00 | Other Are you new to working with human pluripotent stem cells? Experts from the Cell and Gene Technologies Core Facility at Lund University's Lund Stem Cell Center will teach you how from 14 - 18 September, 2026! The 5-day course on the "Handling, maintenance and understanding of human pluripotent stem cells" contains substantial hand-on practi

https://www.stemcellcenter.lu.se/calendar/course-handling-maintenance-and-understanding-human-pluripotent-stem-cells-0 - 2026-07-19

Course: Handling, maintenance and understanding of human pluripotent stem cells

14 September 2026 09:00 to 18 September 2026 17:00 | Other Are you new to working with human pluripotent stem cells? Experts from the Cell and Gene Technologies Core Facility at Lund University's Lund Stem Cell Center will teach you how from 14 - 18 September, 2026! The 5-day course on the "Handling, maintenance and understanding of human pluripotent stem cells" contains substantial hand-on practi

https://www.staff.lu.se/calendar/course-handling-maintenance-and-understanding-human-pluripotent-stem-cells - 2026-07-20

No title

Patients with mantle cell lymphoma (MCL) usually respond to initial combination chemotherapy, but the disease inevitably relapses and often follows an aggressive course. Here, clinical study results published since 2008 for patients with relapsed/refractory MCL were reviewed to compare available evidence for treatment guidance. Most trials identified were non-randomized, phase II studies performed